Evaluation of Early Home Return in Patients With Enucleation of Prostate Adenoma

ConditionAdenoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age45+
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche

About this trial

Prostate adenoma management includes, if necessary, surgical treatments: resection or vaporization by endoscopy or by open surgery in case of a very large prostate. Laser technology is a curative treatment for prostate adenoma. The minimum duration of hospitalization, in the context of enucleation prostatic endoscopy by laser, is estimated at 48 hours.

The Union Clinique has developed an improved rehabilitation care pathway reducing hospitalization duration to 24 hours (one night hospitalization). This care pathway involves patient as an actor in its care but also health professionals, in particular nurses.

This study is based on the hypothesis that the model developed by the Union Clinique can be translated to other healthcare establishments and that home return supervized by nurses allows reducing hospital stay length without increasing the risk of serious complications for patients

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient planned for endoscopic enucleation of prostate adenoma with laser

Patient with symptomatic benign prostatic hyperplasia and refractory to medical reatment and/or

Patient with benign prostatic hyperplasia complicated by chronic retention of urine and/or

Patient with benign prostatic hyperplasia complicated by prostatitis and/or

Disqualifiers

Patient living beyond the scope of care by the nurses coordination

Bedridden patient or WHO clinical condition >2

Patient requiring curative anticoagulation which cannot be interrupted or relayed at home by heparin

Patient with double anti-platelet aggregation who cannot be interrupted

Trial design

Design model

Parallel

Treatments tested in this trial

  • Patient support

    Other intervention

    Patients will be supported by nurses before and after intervention and hospital leave

Treatment groups

440 Participants
are divided into 2 treatment groups
Group A: Early home return armExperimental treatment 1 intervention
Group B: Standard Of Care armNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Re-hospitalizations and/or hospitalization extensions rate

the percentage of re-hospitalizations and/or hospitalization extensions

Time frame
2 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.